Kaoru Harada, MD
Allergy & Immunology · Norwalk, CTNPI 1215383864
Payments from drug & device makers
What this record shows
12 manufacturers reported payments, led by Allerderm Laboratories at 54.7% of the total. Reporting peaked in 2021 at $1,125 and has fallen 97.7% since, to $26 in 2025. That places this record below the midpoint for allergy & immunology clinicians in CT, where the typical reported total is $2,044.
Across 23 payments — averaging $79.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Allerderm Laboratories$1K
- Novartis$169
- Novo Nordisk$125
- AstraZeneca$122
- Optinose US, Inc.$111
- GSK$90
- plus $212 from 6 others
What the payments were for
- Food & beverage$82945%
- Education$1,00055%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Allerderm Laboratories | 1 | $1,000 |
| Novartis | 7 | $169 |
| Novo Nordisk | 1 | $125 |
| AstraZeneca | 1 | $122 |
| Optinose US, Inc. | 1 | $111 |
| GSK | 4 | $90 |
| Alk-abello, Inc | 1 | $59 |
| Genentech USA, Inc. | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Amgen | 1 | $22 |
| Pfizer | 1 | $18 |
| Sanofi | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,829 in reported general payments places this provider in the 45th percentile of 54 allergy & immunology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $15,419 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $8,807 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $4,985 |
| Wixela InhubFluticasone Propion/Salmeterol | 12 | $1,308 |
| Ipratropium Bromide | 23 | $590 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $557 |
| Montelukast Sodium | 33 | $423 |
| Fluticasone Propionate | 18 | $308 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $90 | $29,21155 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 54 allergy & immunology providers in Connecticut.
Other allergy & immunology in Norwalk
- Joseph SprovieroNorwalk$2K
- Agnieszka MatczukNorwalk$1K
- Mark LitchmanNorwalk$486
- Philip HemmersNorwalk$358
- Aymeric LouitNorwalk$338
- Michael LewinNorwalk$238
- Gavin SchwarzWest Hartford$262K
- Christina PriceNew Haven$96K
- Florence HsuNorth Haven$84K
- Jason LeeWest Hartford$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.